Press Releases

Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem

Apr 20, 2018

Iterum Announces the appointment of Jeff Schaffnit as Chief Commercial Officer

Feb 20, 2018

Iterum Therapeutics reveals new US maps highlighting antibiotic resistance ‘hotspots’

Oct 4, 2017

Iterum Gains Important Support for Development of Novel Oral Antibiotic, Sulopenem

Jul 25, 2017

Iterum Secures $65 Million in Series B Financing

May 19, 2017

Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections

Jan 5, 2017

Iterum Therapeutics Licenses Global Rights to Novel Anti-Infective Compound

Mar 24, 2016